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     Levels of serum acid phosphatase are elevated in prostatic cancer patients as com-
pared with those of normal human. Prostatic cancer patients with bone metastasis show 
about 2 to 5 fold increased activities of serum acid phosphatase while patients without 
bone metastasis show slight increase (about 20%) of the activity. When we analysed serum 
acid phosphatase isozyme pattern with DEAE cellulose column chromatography, profiles of 
these enzymes of normal and prostatic cancer patients differ greatly. 
     In normal human, three distinct isozymes I, II and III of serum acid phosphatase were 
observed. Acid phosphatase of prostatic adenoma tissue surgically removed from prostatic 
hypertrophy patients consists of two isozymes II and III which are chromatographically 
corresponding to those isozymes of serum acid phosphatase. Serological analyses and in-
hibitor-enzyme specificities led us to conclude that serum isozymes II and III are derived 
from prostatic gland. 
     In cancer patients without bone metastasis, a greatly increased activity of isozyme 
III and normal level of isozyme II in serum acid phosphatase were observed. However in 
prostatic cancer patient with advanced bone metastasis, a huge increase of serum isozyme 
II activity was observed whereas isozyme III is at an undertectable level. These isozyme 
variations in serum acid phosphatase suggest that assay of each isozyme is a valuable 
approach for diagnosis and judgement of prognosis of prostatic cancer.
                   INTRODUCTION 
     It has long been known that prostatic gland contains large amount of acid phosp-
hatasel), however role of this enzyme is yet unknown. 
     Angeletti et al. 2> reported that serum acid phosphatase has two distinct isozyme
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patterns by DEAF cellulose column chromatography. They showed an increased activity 
of the slow moving peak in prostatic cancer patients. Kondo and Saito" reported purifi-
cation, electrophoresis and enzymologic properties of the acid phosphatase in adenoma 
tissue of prostatic hypertrophy. We subsequently analysed DEAE column chromatography 
patterns of normal serum acid phosphatase, and showed three distinct isozymes, I, II, and 
III. We, furthermore, studied the serological and enzymatic specificities and the origin 
of these isozymes to understand correlation between serum and prostatic acid phosphatases. 
This type of study should add much informations to our understanding diagnostic and 
prognostic approach to prostatic hypertrophy and cancer. 
      In this communication, we report the characterization of each isozyme of serum and 
prostatic acid phosphatases in prostatic diseases and discuss the origins of these isozymes.
               MATERIAL AND METHOD 
     Prostatic acid phosphatase was isolated from sliced tissue of adenoma removed from 
the hypertrophy patient by the methods of London 4~ and Ostrowski5l. Sliced tissues of 
adenoma were suspended in 0.2M acetate buffer, pH 5.0 and incubated at 4°C. Twenty-
four hours later, tissue fragments were removed by filtering through gauge. With this 
procedure, the majority of prostatic acid phosphatase is released into the buffer. The 
enzymes were precipitated by 55-68% saturated ammonium sulfate, resuspended in acetate
buffer and dialysed against the same 
buffer for 24 hrs. at 4°C. This prepara-
tion was applied to DEAE-cellulose (Sigma 
Chemical Co., Saint Louis) column chro-
matography. The detailed diagrammatic 
procedure was shown in Figure 1. Serum 
acid phosphatase was isolated and purified 
by Ostrowski's method from normal hu-
mans and patients with prostatic hypertrophy 
and carcinoma. Serum acid phosphatase 
and prostatic acid phosphatase activities 
were determined quantitatively by the 
methods of Bessey, Lowry and Brock6) 
and Fishman and Lerner7), respectively. 
p-N itrophenyl phosphate (Wako Pure Chem. 
Co. , Osaka) was used as the substrate and 
1-tartaric acid (Sigma Chemical Co. , Saint 
Louis) as inhibitor of prostatic acid phos-
phatase. Rabbit antiserum against human 
prostatic acid phosphatase was prepared 
by inoculating 2 mg proteins of enzyme with
Fig. 1 Isolation Procedure of Prostatic Acid 
      Phosphatase
Freund's complete adjuvant (Difco, Detroit) once a week a total of 4 times. The specificity 
of this antiserum against prostatic acid phosphatase was assayed by serological absorption 
method. Agar (Sigma Chemical Co., Saint Louis) gel electrophoresis was carried out on 
microscopic slide glass at 6V per cm for 90 min. in a barbital buffer, pH 8.2, at an 
ionic strength of 0.05 M and then immunoelectrophoresis was done according to the methods 
of Scheidegger'). 
                     RESULTS 
Comparative chromatographic analyses of acid phosphatase of serum and prostatic adenoma 
tissue 
     A typical chromatographic profile of serum acid phosphatase of normal male humans 
is shown in Fig. 2. Two major peaks Is and Its and one minor peak Ills were observed. 
Relative acid phosphatase activities of Is, Its and Ills are about 73, 27 and 1% respec-
tively. Thus, serum acid phosphatase consists of three isozymes. Acid phosphatase isolated 
from adenoma tissue of hypertrophic patients shows two major peaks Hp and IIIp corres-
ponding to the Its and Ills isozymes of serum acid phosphatase (Fig. 3). Although, the 
level of serum acid phosphatase isozyme Ills activity is a barely detectable level (about 1 
  of the total activity), the relative activity of the prostatic acid phosphatase peak IIIp
is about 40% of the total prostatic acid phosphatase. Occasionally an additional minor 
isozyme peak Ip in front of peak Hp was found in extracts from prostate tissue. Since 
this minor isozyme Ip appears occasionally, it is possible that the Ip isozyme is a decomposed
Fig. 2 Column chromatography of normal serum
Fig. 3 DEAE cellulose column chromatography of acid Phosphatase from 
       prostatic hypertrophy
product of other isozymes. 
     In serum acid phosphatase of prostatic cancer patients without bone metastasis, an 
elevated isozyme IIIs activity was observed as shown in Table 1, whereas isozyme Its 
activity is about the same as those of normal and of hypertrophy patient. Serum acid 
phosphatase of cancer patient with advanced bone metastasis shows isozyme Its exclusively. 
The level of isozyme Its activity was about 20-fold higher than that of normal human 
serum. Two other peaks were almost undetected (Fig. 4). These observations indicate that 
formation of cancer accompanies with change in pattern of serum acid phosphatase. There-
fore it may be suggested that these two isozymes Its and IIIs are prostate specific acid 
phosphatase.
          Table 1. Acid phosphatase activity of sera 
                                       total isozyme activity (°o of total activity) 
                sera activity 
                             (mM/l/hr) Is Ils Ills 
normal male serum 0.592±0.097 72.7±4.4 26.7±4.8 0.7±1.1 
BPH serum 0.778±0.386 74.2±6.0 24.3±7.5 1.5±1.8 
                  no bone 0 .698±0.267 60.4±6.7 27.0±4.7 12.6±4.2 
sera of prostatic metastasis 
carcinoma with 
advanced bone 
                  metastasis 30.150 0.1 99.9 0
Fig. 4 Column chromatography of the patient with metastatic cancer of Prostate
Rechromatography of the prostatic isozyme lip 
     Since a drastic increase in the Its isozyme activity of serum acid phosphatase was 
found in prostatic cancer patients with advanced bone metastasis, the detailed characteri-
zation of the isozymes Its and Hp may provide valuable informations for disease processes. 
We, thus, rechromatographed the peak Hp fraction of prostatic acid phosphatase. As 
shown in Fig. 5, we obtained a single peak (designated as Ilpr hereafter) without contami-
nation of IIIp and minor peak Ip isozymes. This result indicates that isozyme Hp can be 
purified by DEAE cellulose column chromatography. Thus, the isozyme Ip may probably 
be an independent isozyme, although the possibility that the isozyme Ip is a decomposed 
product of isozyme lip may not be excluded. 
Serological identification of prostatic acid phosphatase 
     In recent years, immunological techniques became available for crucial identification 
of homologous and non homologous enzymes9~10). Therefore, it was of great interest to study 
antigenicity of these acid phosphatase isozymes. We immunized rabbits with IIpr isozyme 
by injecting 2mg IIpr protein preparation per a week for a total of four injections. The 
resulting anti-IIpr serum was mixed with the Ilpr isozyme preparation, incubated for one 
hour at 37°C and centrifuged at 8,000 rpm for 30 min. Enzyme activity of supernatant
Fig. 5 Rechromatography of III Fr on DEAE-cellulose column
was about 3% of untreated Ilpr isozyme activity (Table 2). In considering small amounts 
of non precipitable enzyme-antibody complex, We believe that 100% of the enzyme was 
neutralized by the antibodies. 
     When anti-IIpr serum was mixed with serum acid phosphatase isozyme Its of normal 
human followed by one hour incubation and centrifugation, the residual enzyme activity 
in supernatant was about 90% of the untreated Its isozyme activity (Table 2). This obser-
vation suggests that the peak Its of serum acid phosphatase consists of at least two different 
isozyme origins. One of them should be derived from prostatic gland (about 10%) and 
the other is unknown. Since a drastically elevated activity of serum acid phosphatase Its 
isozyme was observed in prostatic cancer patients with advanced bone metastasis, the anti-
genecity of this isozyme (designated IIsm hereafter) was examined with anti-Ilpr serum. 
About 95% of the enzyme activity was neutralized (Table 2). This result indicates that 
the enzyme activity of the peak IIsm consists of mainly prostatic acid phosphatase Hp and 
small amounts (less than 5%) of acid phosphatase of other origin. 
Characterization of prostatic acid phosphatase 
a) pH dependency 
     The pH dependency of enzyme activity of the rechromatographed Ilpr was studied. 
As shown in Fig. 6, two optimal peaks at pH 3.8 and 5.5 were observed. In contrast, 
the optimal pH for the activity of normal serum acid phosphatase isozyme Its is about 5.0.
          Table 2 Absorption and inhibition of enzyme 
                                                               activity of enzyme 
            acid phosphatase absorption inhibition 
                                              by by 
                                                             anti-Ilpr serum 1-tartrate
                                total 30 
normal serum acid phosphatase Is 50 51 
                                 isozymes IIs 10 35
                                                HIS - 20 
                                total 36 
                 no bone Is 27 27 
serum acid metastasis isozymes IIs 75 75 
phosphatase HIS 33 43 
of prostatic total 84 
carcinoma with 
                 advanced bone Is 26 26 
                  metastasis isozymes IIs* 95 95
                                              HIS - -
                              total 94
acid phosphatase of prostatic Ip 100 90 
adenoma tissue isozymes Ilp 100 95 
                                   HIP 100 93
                                 - indicates undetectable activity 
                                 * this particular isozyme Ils of adenocarcinoma with bone 
                                   metastasis is designated Ilsm for frequent use in the text.
These results led us to conclude that prostatic acid phosphatase isozyme IIpr is distinguish-
able from serum acid phosphatase isozyme Us by pH dependency. As can be seen in 
this figure, however, the pH dependency of the serum acid phosphatase isozyme Hs activity 
showed a quite broad peak. The serum Hs activities corresponding to the optimal pHs 
(3.8 and 5.5) of prostatic acid phosphatase isozyme IIpr are relatively high, indicating 
that the normal serum acid phosphatase isozyme Hs may be composed of prostatic acid phos-
phatase and those of other origins. These observation with pH dependency and the previously 
mentioned serological test suggest that perhaps only 10% of the serum acid phosphatase 
isozyme IIs is derived from prostatic gland. The remaining 90% is originated from other 
organs. 
b) Inhibition by 1-tartrate 
     Fishman and Lerner7 reported that 1-tartrate inhibits prostate specific acid phos-
phatase in serum. Thus, it became desirable to study specific inhibition of serum and 
prostatic acid phosphatase isozymes. 1-Tartrate inhibits 30% of whole serum enzyme activity 
of normal male whereas it inhibits about 94% of whole prostatic acid phosphatase activity 
extracted from prostatic adenoma tissue, as shown in Table 2. Subsequently, we studied 
inhibition of each prostatic and serum acid phosphatase isozyme. 1-Tartrate inhibitions of
Fig. 6 Optimum pH of IIpr, Is and Its
prostatic acid phosphatase isozymes Ip, IIp, and IIIp from prostatic adenoma tissue were 
90, 95 and 93% respectively. However, 1-tartrate inhibited 51% of isozyme Is, 35% of 
isozyme Its and 20% of isozyme IIIs activities of normal male human serum. On the other 
hand, isozymes Its of prostatic cancer patients without bone metastasis and with bone 
metastasis (Ilms) were inhibited by 75% and 95% respectively. These experiments suggest-
ed that 1-tartrate is not a specific inhibitor for normal serum acid phosphatase isozymes 
Its and IIIs although it preferentially inhibits Its and urns of cancer patients. Since we 
suggested that serum acid phosphatase isozymes Its and IIIs are derived from prostate, it 
should not be concluded that 1-tartrate specifically inhibits prostatic acid phosphatase in 
normal sera. 
Immunoelectrophoretic analysis of prostatic acid phosphatase 
     When acid phosphatase preparation derived from adenoma tissues of prostatic hy-
pertrophy was submitted to immunoelectrophoretic analysis, three distinct bands were found. 
Isozymes Ilpr and IIIp corresponding to those of DEAE cellulose column chromatography
Fig. 7 Immunoelectrophoresis of 1p, Hp and 111p.
of acid phosphatase migrate toward cathode. Isozyme IIIp moves faster than isozyme IIpr 
as shown in Fig. 7. The minor isozyme Ip of prostatic acid phosphatase migrate toward 
anode. From this observation, it is defenitely concluded that prostatic acid phosphatase 
has three distinct isozymes, Ip, IIp, and IIIp.
                    DISCUSSION 
     When anti-IIpr serum was mixed with prostatic isozyme IIIp and followed by absorp-
tion and precipitation procedure, more than 90% of the enzyme activity was lost, indicating 
that isozymes IIp and IIIp were serologically indistinguishable. This may suggest that these 
two isozymes are the products of a single structural gene or these isozymes share a common 
subunit. In addition anti-IIpr serum also crossreact with isozyme Ip, implying that it 
shares common antigen with the other two isozymes (IIp and IIIp). However the isozyme 
Ip moved opposite direction from the other two isozymes in electrophoresis. 
     It should be mentioned here that anti-IIpr serum can absorb about 19% activity of 
isozyme Its of female serum acid phosphatase. This observation led us to hypothesize that 
though female does not have the prostatic gland the female serum acid phosphatase isozyme 
Its share a common subunit with the prostatic isozymes. Recently, Suyama et al. 12) observed 
that treatment of seminal fluid acid phosphatase with neuraminidase results in retarded 
mobility of electrophoretic patterns of the isozymes IIp and IIIp. Therefore it seems likely 
that protein modification by sialic acid increases negative charge which accelerate electro-
phoretic mobility. 
     This possibility may be a formation of multiple isozymes by modification of product
of a single structural gene and may explain that the number of sialic acid on isozyme 
IIIp is more than that of isozyme IIp. 
     In our separate study") with various human organs, it may be suggested that isozyme 
Is and a portion of the isozyme Its are derived from various other organs such as liver, 
kidney, red blood cells and bone marrow. The critical determination of origin and serologi-
cal cross-reactivity of each isozyme of acid phosphatases should shed lights on mechanism 
of isozyme formation. 
     In the present publication, we have shown that male serum acid phosphatase isozymes 
Its and Ills are derived from prostatic gland and that isozymes Its and Ills activities are 
drastically elevated by formation of prostatic cancer with or without bone metastasis. 
Therefore the determination of activities of serum acid phosphatase isozymes Its and Ills 
provides powerful diagnostic tool for prostatic cancer.
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